The field of cancer immunology has witnessed dramatic progress with the advent of immunotherapies targeting the tumor immune microenvironment (TIME).

Phase 1 proof-of-concept study of CLY-124 in Sickle Cell Disease expected in Q4 2026 In vivo preclinical data assessing new compounds vs. standard of care in gold-standard, translatable myelofibrosis ...

Illumina, whose EMEA head office is at Granta Park in Cambridge, has released Illumina Connected Multiomics, a powerful cloud ...

The field of immunotherapy has revolutionized the treatment of advanced non-small cell lung cancer (NSCLC), particularly ...

Researchers developed two computational tools to decode how cells communicate in tissues. sCCIgen creates realistic virtual ...

In a paper published in the journal Nature Neuroscience, researchers have mapped how stress events during pregnancy can ...

Illumina, Inc. (NASDAQ: ILMN) today announced the release of Illumina Connected Multiomics, a powerful cloud-based research ...

The pelvis is often called the keystone of upright movement. It helps explain how human ancestors left life on all fours ...

STORIES is a trajectory inference method capable of learning a causal model of cellular differentiation from spatial transcriptomics through time using Fused Gromov-Wasserstein. STORIES learns a ...

Transcriptomics Data Analysis (TDA) is a live, instructor-led training program designed to introduce participants to best practices in the analysis of high-throughput RNA sequencing (RNA-seq) data.